Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
LFCR Lifecore Biomedical Inc
- Stocks
- Healthcare
- NASDAQ: LFCR
Price (delayed)
$6.89
Market cap
$255.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.48
Enterprise value
$379.1M
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for
Highlights
The company's quick ratio rose by 39% YoY and by 16% QoQ
LFCR's revenue is up by 7% YoY
Lifecore Biomedical's gross profit has increased by 35% YoY but it has decreased by 4.5% QoQ
The company's gross margin rose by 26% YoY but it fell by 4.3% QoQ
LFCR's EPS has shrunk by 196% QoQ and by 121% YoY
Lifecore Biomedical's net income has plunged by 121% YoY
Key stats
What are the main financial stats of LFCR
Market
Valuations
Earnings
Shares outstanding
37.03M
Market cap
$255.1M
Enterprise value
$379.1M
Price to earnings (P/E)
N/A
Price to book (P/B)
114.45
Price to sales (P/S)
1.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.91
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
EBIT
-$22.6M
EBITDA
-$14.23M
Free cash flow
-$3.87M
Per share
Balance sheet
Liquidity
EPS
-$1.48
EPS diluted
-$1.45
Free cash flow per share
-$0.1
Book value per share
$0.06
Revenue per share
$3.52
TBVPS
$5.93
Total assets
$237.69M
Total liabilities
$190.27M
Debt
$129.41M
Equity
$2.23M
Working capital
$53.1M
Debt to equity
58.06
Current ratio
2.71
Quick ratio
1.31
Net debt/EBITDA
-8.71
Margins
Efficiency
Dividend
EBITDA margin
-10.9%
Gross margin
33.4%
Net margin
-34.3%
Operating margin
-15.7%
Return on assets
-19.9%
Return on equity
-788.6%
Return on invested capital
-7.1%
Return on capital employed
-10.9%
Return on sales
-17.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFCR stock price
How has the Lifecore Biomedical stock price performed over time
Intraday
-1.57%
1 week
0.88%
1 month
32.25%
1 year
3.61%
YTD
-7.27%
QTD
-2.13%
Financial performance
How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
Gross margin
33.4%
Net margin
-34.3%
Lifecore Biomedical's net income has plunged by 121% YoY
Lifecore Biomedical's net margin has plunged by 107% YoY
LFCR's operating margin has plunged by 67% from the previous quarter and by 8% YoY
The company's operating income has shrunk by 66% QoQ and by 16% YoY
Price vs fundamentals
How does LFCR's price correlate with its fundamentals
Growth
What is Lifecore Biomedical's growth rate over time
Valuation
What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
114.45
P/S
1.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.91
LFCR's EPS has shrunk by 196% QoQ and by 121% YoY
LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter
The price to sales (P/S) is 23% higher than the last 4 quarters average of 1.6 but 22% lower than the 5-year quarterly average of 2.5
LFCR's revenue is up by 7% YoY
Efficiency
How efficient is Lifecore Biomedical business performance
The ROA has plunged by 146% YoY
Lifecore Biomedical's ROE has soared by 87% YoY
Dividends
What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFCR.
Financial health
How did Lifecore Biomedical financials performed over time
LFCR's total assets is 25% more than its total liabilities
The company's quick ratio rose by 39% YoY and by 16% QoQ
The company's current ratio rose by 31% YoY and by 17% QoQ
LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter
Lifecore Biomedical's debt has increased by 2.5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.